Candel Therapeutics Inc. Gains 37.76%
Mon, Nov 06, 2023 at 07:09 PM
Candel Therapeutics Inc. (CADL:NASDAQ) rocketted at $0.93, a gain of 37.8%. On Mon, Nov 06, 2023, CADL:NASDAQ hit a New 2-Week High of $0.93. The stock appeared on our News Catalysts scanner on Sat, Nov 04, 2023 at 09:18 AM in the 'BIOTECH' category. From Mon, Oct 23, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
About Candel Therapeutics Inc. (CADL:NASDAQ)
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
Top 10 Gainers:
- MSP Recovery Inc. (LIFW:NASDAQ), 252.19%
- Carbon Revolution Public Limited Company (CREV:NASDAQ), 197.99%
- Bluegreen Vacations Holding Corporation Class A (BVH:NYSE), 106.79%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 81.62%
- Vinco Ventures Inc. (BBIG:NASDAQ), 76.47%
- Tenon Medical Inc. (TNON:NASDAQ), 57.48%
- Cheetah Net Supply Chain Service Inc. (CTNT:NASDAQ), 53.04%
- Color Star Technology Co. Ltd. (ADD:NASDAQ), 43.85%
- Troika Media Group Inc. (TRKA:NASDAQ), 38.46%
- Candel Therapeutics Inc. (CADL:NASDAQ), 37.76%